Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Uric Acid among Adults with Elevated Community Exposure to PFOA
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are compounds that do not occur in nature, have been widely used since World War II, and persist indefinitely in most environments. Median serum levels in the United States are 4 ng/mL for PFOA and 21 ng/mL for PFOS. PFOA has been associated with elevated uric acid in two studies of chemical workers. Uric acid is a risk factor for hypertension and possibly other cardiovascular outcomes. Methods: We conducted a cross-sectional study of PFOA and PFOS and uric acid among 54,951 adult community residents in Ohio and West Virginia, who lived or worked in six water districts contaminated with PFOA from a chemical plant. Analyses were conducted by linear and logistic regression, adjusted for confounders. Results: Both PFOA and PFOS were significantly associated with uric acid. An increase of 0.2–0.3 mg/dL uric acid was associated with an increase from the lowest to highest decile of either PFOA or PFOS. Hyperuricemia risk increased modestly with increasing PFOA; the odds ratios by quintile of PFOA were 1.00, 1.33 [95% confidence interval (CI), 1.24–1.43], 1.35 (95% CI, 1.26–1.45), 1.47 (95% CI, 1.37–1.58), and 1.47 (95% CI, 1.37–1.58; test for trend, p < 0.0001). We saw a less steep trend for PFOS. Inclusion of both correlated fluorocarbons in the model indicated PFOA was a more important predictor than was PFOS. Conclusion: Higher serum levels of PFOA were associated with a higher prevalence of hyperuricemia, but the limitations of cross-sectional data and the possibility of noncausal mechanisms prohibit conclusions regarding causality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Steenland et al. interrogated the association between uric acid and PFCs and concluded that the PFOA serum concentrations were significantly related to a higher rate of hyperuricemia, which is a potential risk factor for hypertension and other cardiovascular diseases [33].”
From Overview of emerging contaminants and associated human health effects (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · cited 4×
“In addition, PFOA has been associated with a number of outcomes in animal data, par ticularly tumors and neonatal loss (Lau et al. 2007; U.S. EPA 2005).”
BackgroundInfluentialOlsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049 · cited 3×
“PFOA exposure was observed to be associ ated with a 2fold increase in diabetes mor tality in one cohort study of highly exposed workers compared with nonexposed workers, although no association was seen in another crosssectional study of diabetes prevalence (Leonard et al. 2008; MacNeil et al.…”
BackgroundResultInfluentialSerum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513 · cited 1×
“…hand, there is debate about whether uric acid is a predictor of cardiovascular disease, indepen dent of other known risk factors, and inde pendent of its role as a marker of kidney disease (Fang and Alderman 2000; Hakoda et al. 2005; Johnson et al. 2003; Shankar et al. 2006; Wannamethee 2005).”
BackgroundIs There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361 · cited 2×
“…hand, there is debate about whether uric acid is a predictor of cardiovascular disease, indepen dent of other known risk factors, and inde pendent of its role as a marker of kidney disease (Fang and Alderman 2000; Hakoda et al. 2005; Johnson et al. 2003; Shankar et al. 2006; Wannamethee 2005).”
BackgroundMethodInfluentialCalafat, A. M., Wong, L.-Y., Kuklenyik, Z., Reidy, J. A., & Needham, L. L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10598 · Cited by 1,247 · cited 6×
“…Health Perspectives • volume 118 | number 2 | February 2010 229 Research Perfluorooctanoic acid (PFOA) and perfluoro octane sulfonate (PFOS) are perfluorinated compounds that have been found in the blood of virtually all Americans tested during the last decade (Calafat et al. 2007).”
BackgroundInfluentialFeig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914 · cited 2×
“A recent ran domized trial found that lowering uric acid resulted in lowering blood pressure in adoles cents (Feig et al. 2008).”
BackgroundRelations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence
Sundström, J., Sullivan, L., D’Agostino, R. B., Levy, D., Kannel, W. B., & Vasan, R. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000150784.92944.9a · Cited by 491
Hayden, M. R., & Tyagi, S. C. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-10 · Cited by 397 · cited 2×
“In one cross sectional study of PFOS and cholesterol, a sta tistically significant positive association was observed among workers at one plant, but not at a second plant (Olsen et al. 1999).”
BackgroundSteenland, K., Tinker, S., Frisbee, S., Ducatman, A., & Vaccarino, V. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp279 · Cited by 371 · cited 1×
“Considerable epidemiologic evidence exists from longitudinal studies, sup ported by animal evidence, that elevated uric acid is a risk factor for hypertension (Feig et al. 2006; Mellen et al. 2006; Shankar et al. 2006; Sundström et al. 2005).”
BackgroundSelf-citationOlsen, G. W., Burris, J. M., Burlew, M. M., & Mandel, J. H. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000052958.59271.10 · Cited by 363 · cited 1×
“In one cross sectional study of PFOS and cholesterol, a sta tistically significant positive association was observed among workers at one plant, but not at a second plant (Olsen et al. 1999).”
Background
Cited by
Items 101–200 of 225
Perfluorooctanesulfonate Mediates Renal Tubular Cell Apoptosis through PPARgamma Inactivation
Wen, L.-L., Lin, C.-Y., Chou, H.-C., Chang, C.-C., Lo, H.-Y., & Juan, S.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155190 · Cited by 63
“A previous study showed that serum PFCs have been detected in greater than 98% of the US population, which is associated with several risk factors for diseases, including increased total and low-density lipoprotein cholesterol [6, 7], increased uric acid levels [6, 8], increased risk of diabetes and metabolic syndrome…”
BackgroundPerfluoroalkyl chemicals and elevated serum uric acid in US adults
Shankar, A., Xiao, J., & Ducatman, A. (2011) · Clinical Epidemiology · doi:10.2147/clep.s21677 · Cited by 59
“Recently, Steenland et al 15 reported modest positive associations between both serum perfluorooctanoic acid and perfluorooctane sulfonate levels and elevated uric acid in the C8 Health Study, a community-based study of residents in six water districts in Ohio and West Virginia who were exposed to very high levels of…”
InfluentialSelf-citationYou, L., Zheng, F., Su, C., Wang, L., Li, X., Chen, Q., Kou, J., Wang, X., Wang, Y., Wang, Y., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106919 · Cited by 62
Jing, Y., He, C., Liu, X., Wu, J. W., Hu, Y. D., & Ya, Z. (2013) · Desalination · doi:10.1016/j.desal.2013.08.007 · Cited by 64
Lin, C.-Y., Wen, L., Lin, L.-Y., Wen, T.-W., Lien, G.-W., Chen, C.-Y., Hsu, S. H. J., Chien, K.-L., Sung, F.-C., Chen, P.-C., et al. (2011) · Environmental Science & Technology · doi:10.1021/es201964x · Cited by 61
Lin, C., Chen, P., Lo, S., Torng, P., Sung, F., & Su, T. (2016) · Environment International · doi:10.1016/j.envint.2016.06.004 · Cited by 61
Winquist, A. G., Steenland, K., & Shankar, A. (2010) · Movement Disorders · doi:10.1002/mds.23070 · Cited by 61
Self-citationQin, X.-D., Qian, Z. M., Vaughn, M. G., Huang, J., Ward, P., Zeng, X., Zhou, Y., Zhu, Y., Yuan, P., Li, M., et al. (2016) · Environmental Pollution · doi:10.1016/j.envpol.2016.02.050 · Cited by 62
Schümann, M., Lilienthal, H., & Hölzer, J. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104868 · Cited by 65
Marumure, J., Simbanegavi, T. T., Makuvara, Z., Karidzagundi, R., Alufasi, R., Goredema, M., Gufe, C., Chaukura, N., Halabowski, D., & Gwenzi, W. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.141699 · Cited by 70
Jain, R. B. (2018) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.07.198 · Cited by 57
Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009–2014
Scinicariello, F., Buser, M. C., Balluz, L., Gehle, K., Murray, H. E., Abadin, H. G., & Attanasio, R. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.127446 · Cited by 54
“We summed the concentrations of the branched and linear isomers to obtain total PFOA and PFOS concentrations (Ye et al., 2018).”
BackgroundInfluentialInnes, K. E., & Sambamoorthi, U. (2017) · Pain Medicine · doi:10.1093/pm/pnx107 · Cited by 63
Convertino, M., Church, T. R., Olsen, G. W., Liu, Y., Doyle, E., Elcombe, C. R., Barnett, A. L., Samuel, L. M., MacPherson, I. R., & Evans, T. R. J. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy035 · Cited by 54
“…chronic kidney disease in children and adults with PFOA (Kataria et al. , 2015; Shankar et al. , 2011a) or with hyperuricemia (Geiger et al. , 2013; Shankar 2011b; Steenland et al. , 2010b); however, these findings were likely confounded by the GFR (Watkins et al. , 2013; Dhingra et al. , 2017).”
BackgroundResultBao, J., Yu, W., Liu, Y., Wang, X., Liu, Z., & Duan, Y.-F. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.125951 · Cited by 58
Jin, B., Mallula, S., Golovko, S. A., Golovko, M. Y., & Xiao, F. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c01644 · Cited by 54
Innes, K. E., Wimsatt, J. H., Frisbee, S., & Ducatman, A. M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-45 · Cited by 50
“Estimated participation rate in the C8 Health Project among adult residents of the affected water districts was 81% [19].”
Self-citationOrešič, M., McGlinchey, A. J., Wheelock, C. E., & Hyötyläinen, T. (2020) · Metabolites · doi:10.3390/metabo10110454 · Cited by 55
“Perfluorooctanoic acid (PFOA), a widely used PFAS, was also found to be significantly associated with elevated uric acid in several studies [24,96].”
BackgroundInnes, K. E., Ducatman, A. M., Luster, M. I., & Shankar, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr107 · Cited by 48
Self-citationSubchronic Effects of Perfluorooctanesulfonate Exposure on Inflammation in Adult Male C57BL/6 Mice
Dong, G., Zhang, Y., Zheng, L., Liang, Z., Jin, Y., & He, Q. (2012) · Environmental Toxicology · doi:10.1002/tox.20642 · Cited by 49
“…in humans has revealed that elevated concentrations of serum PFOS are associated with thyroid disease, low birth weight, preeclampsia, a reduced normal sperm count, and an increased prevalence of hyperuricemia (Stein et al., 2009; Joensen et al., 2009; Melzer et al., 2010; Steenland et al., 2010).”
BackgroundWang, Z., Alinezhad, A., Sun, R., Xiao, F., & Pignatello, J. J. (2023) · ACS ES&T Engineering · doi:10.1021/acsestengg.2c00271 · Cited by 51
Chen, A., Jandarov, R., Zhou, L., Calafat, A. M., Zhang, G., Urbina, E. M., Sarac, J., Augustin, D. H., Caric, T., Bockor, L., et al. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.250 · Cited by 48
“Previous studies have suggested associations between PFAS exposure and increased concentrations of total cholesterol, uric acid, glucose, insulin resistance, glycated hemoglobin (HbA1c) (Cardenas et al., 2017; Steenland et al., 2009; Steenland et al., 2010), but the association between PFAS exposure and metabolic synd…”
BackgroundHölzer, J., Lilienthal, H., & Schümann, M. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104862 · Cited by 54
Dehghani, M., Aghaei, M., Bashardoust, P., Ghalhari, M. R., Nayeri, D., Malekpoor, M., Sheikhi, S., & Shi, Z. (2025) · Environmental Sciences Europe · doi:10.1186/s12302-025-01122-9 · Cited by 55
“The levels of PFAS compounds in individuals who are exposed to PFAS occupationally is about hundreds of times higher than those whom are exposed to PFAS compounds from non-occupational routes [108].”
Moon, J. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117707 · Cited by 46
Bao, J., Shao, L.-X., Liu, Y., Cui, S.-W., Wang, X., Lu, G.-L., Wang, X., & Jin, Y.-H. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.135731 · Cited by 43
Dietary predictors and plasma concentrations of perfluorinated alkyl acids in a Singapore population
Liu, Y., Su, J., van Dam, R. M., Prem, K., Hoong, J. Y. S., Zou, L., Lu, Y., & Ong, C. N. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.12.107 · Cited by 44
Kowalczyk, J., Numata, J., Zimmermann, B., Klinger, R. J., Habedank, F., Just, P., Schafft, H. A., & Lahrssen‐Wiederholt, M. (2018) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-018-0552-8 · Cited by 48
Ducatman, A., Luster, M., & Fletcher, T. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103650 · Cited by 42
Self-citationAn interlaboratory study of perfluorinated alkyl compound levels in human plasma
Longnecker, M. P., Smith, C. S., Kissling, G. E., Hoppin, J. A., Butenhoff, J. L., Decker, E., Ehresman, D. J., Ellefson, M. E., Flaherty, J. M., Gardner, M. S., et al. (2008) · Environmental Research · doi:10.1016/j.envres.2008.01.005 · Cited by 42
Simpson, C., Winquist, A. G., Lally, C. A., & Steenland, K. (2013) · Environmental Research · doi:10.1016/j.envres.2013.10.002 · Cited by 44
Self-citationEvaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes
Rosen, M. B., Das, K. P., Wood, C. R., Wolf, C. J., Abbott, B. D., & Lau, C. S. (2013) · Toxicology · doi:10.1016/j.tox.2013.03.011 · Cited by 41
Lin, T.-W., Chen, M., Lin, C., Chen, M., Tsai, M., Chan, D., Hung, K., & Chen, P. (2020) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2020.113607 · Cited by 41
No association between perfluoroalkyl chemicals and hypertension in children
Geiger, S., Shankar, A., & Xiao, J. (2014) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s47660 · Cited by 36
Self-citationJain, R. B., & DUCATMAN, A. M. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-04666-5 · Cited by 39
Self-citationHonda-Kohmo, K., Hutcheson, R., Innes, K. E., & Conway, B. N. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.02.004 · Cited by 38
Dong, G., Wang, J., Zhang, Y.-H., Liu, M.-M., Da, W., Zheng, L., & Jin, Y. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.010 · Cited by 38
Jiang, Q., Gao, H., & Zhang, L. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15518-0_7 · Cited by 45
Osorio-Yáñez, C., Sanchez-Guerra, M., Cardenas, A., Lin, P.-I. D., Hauser, R., Gold, D. R., Kleinman, K. P., Hivert, M.-F., Fleisch, A. F., Calafat, A. M., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106446 · Cited by 36
“, 2009), uric acid increase (Steenland et al., 2010) and insulin resistance (Cardenas et al.”
BackgroundOfficial health communications are failing PFAS-contaminated communities
DUCATMAN, A. M., LaPier, J., Fuoco, R. E., & DeWitt, J. C. (2022) · Environmental Health · doi:10.1186/s12940-022-00857-9 · Cited by 35
Self-citationCui, R., Zhang, H., Guo, X., Cui, Q., Wang, J., & Dai, J. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.06.031 · Cited by 34
Romano, M. E., Gallagher, L. G., Eliot, M., Calafat, A. M., Chen, A., Yolton, K. A., Lanphear, B. P., & Braun, J. M. (2020) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2020.113660 · Cited by 31
“Other studies have suggested associations between PFAS exposure and increased concentrations of total cholesterol, uric acid, glucose, insulin resistance, glycated hemoglobin (HbA1c) (Cardenas et al., 2017; Steenland et al., 2009; Steenland et al., 2010).”
BackgroundHapponen, M., Koivusalo, H., Malve, O., Perkola, N., Juntunen, J., & Huttula, T. H. (2015) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2015.09.008 · Cited by 33
Per- and polyfluorinated substances in the Nordic Countries
Posner, S., Roos, S., Poulsen, P. B., Jörundsdóttir, H. Ó., Gunnlaugsdóttir, H., Trier, X., Jensen, A. A., Katsogiannis, A. A., Herzke, D., Bonefeld‐Jørgensen, E. C., et al. (2013) · doi:10.6027/tn2013-542 · Cited by 43
Liu, Y., Bao, J., Hu, X., Lu, G.-L., Yu, W., & Meng, Z. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.104673 · Cited by 33
Polyfluorinated Alkyl Phosphate Ester Surfactants – Current Knowledge and Knowledge Gaps
Taxvig, C., Rosenmai, A. K., & Vinggaard, A. M. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12208 · Cited by 31
Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid
Eldasher, L. M., Wen, X., Little, M. S., Bircsak, K. M., Yacovino, L. L., & Aleksunes, L. M. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.009 · Cited by 33
“A number of adverse health effects including hyperuricemia (Steenland et al., 2010) and hypercholesterolemia (Costa et al.”
BackgroundKimura, O., Fujii, Y., Haraguchi, K., Kato, Y., Ohta, C., Koga, N., & Endo, T. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.05.012 · Cited by 29
“However, various adverse health effects including hyperuricemia (Steenland et al., 2010) and hypercholesterolemia (Steenland et al., 2009; Frisbee et al., 2010) have been reported in workers occupationally exposed to PFOA and residents consuming drinking water contaminated with PFOA from a chemical…”
BackgroundZheng, X., Pan, Y., Qu, Y., Ji, S., Wang, J., Li, Z., Zhao, F., Wu, B., Xie, L., Li, Y., et al. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.3c11095 · Cited by 31
Elgarahy, A. M., Eloffy, M. G., Saber, A. N., Abouzid, M., Rashad, E., Ghorab, M. A., El‐Sherif, D. M., & Elwakeel, K. Z. (2024) · Environmental Monitoring and Assessment · doi:10.1007/s10661-024-13334-2 · Cited by 31
Perfluoroalkyl substances exposure and hearing impairment in US adults
Ding, N., & Park, S. K. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109686 · Cited by 29
“, 2018), and abnormal blood pressure (Bao et al., 2017; Min et al., 2012; Steenland et al., 2010).”
Pavúk, M., Adgate, J. L., Bartell, S. M., Bell, E. M., Brown, L. M., Laumbach, R. J., Schaider, L. A., Erve, T. J. V. ‘., Bailey, J. M., Botelho, J. C., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109589 · Cited by 31
The chemical disruption of human metabolism
Genuis, S. J., & Kyrillos, E. (2017) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2017.1323986 · Cited by 30
“In fact, it has become apparent that myriad chemical agents exert significant impact at seemingly miniscule doses (Welshons et al. 2003; Canfield et al. 2003), with incremental influence for many pollutants at increasing levels of accrual (Frisbee et al. 2010; Steenland et al. 2010).”
BackgroundA metabolomic investigation of serum perfluorooctane sulfonate and perfluorooctanoate
Rhee, J., Loftfield, E., Albanes, D., Layne, T. M., Stolzenberg‐Solomon, R. Z., Liao, L. M., Playdon, M. C., Berndt, S. I., Sampson, J. N., Freedman, N. D., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108198 · Cited by 26
Human exposure to perfluoroalkyl substances near a fluorochemical industrial park in China
Bao, J., Liu, L., Wang, X., Jin, Y., & Dong, G. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-8620-6 · Cited by 25
“For instance, higher serum concentrations of PFOS and PFOA might be significantly associated with elevated cholesterol (Nelson et al. 2010) and uric acid (Steenland et al. 2010), as well as an increased risk of current thyroid disease (Melzer et al. 2010).”
BackgroundPerfluoroalkyl substances and likelihood of stroke in persons with and without diabetes
Hutcheson, R., Innes, K. E., & Conway, B. N. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119892223 · Cited by 27
An Overview of the Formation of PFOA and PFOS in Drinking-Water and Wastewater Treatment Processes
Xiao, F. (2022) · Journal of Environmental Engineering · doi:10.1061/(asce)ee.1943-7870.0001986 · Cited by 25
Sukhram, S. D., Kim, J., Musovic, S., Anidugbe, A., Corte, E., Ahsan, T., Rofail, S., Mesquita, N., & Padilla, M. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22071116 · Cited by 24
“For example, communities in Ohio and West Virginia have documented elevated PFAS concentrations in local water sources [105,106].”
PFASs in the General Population
Kato, K., Ye, X., & Calafat, A. M. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15518-0_3 · Cited by 28
Persistent Organic Pollutants: An Overview
Wikoff, D. S., Fitzgerald, L., & Birnbaum, L. S. (2012) · Wiley eBooks · doi:10.1002/9781118184141.ch1 · Cited by 24
Ye, W.-L., Chen, Z.-X., Xie, Y.-Q., Kong, M., Li, Q., Yu, S., Chu, C., Dong, G., & Zeng, X. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110430 · Cited by 24
Kerger, B. D., Copeland, T. L., & DeCaprio, A. P. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.582502 · Cited by 24
“…that utilize low dose quartiles as the referent group for serum PFOA/PFOS have reported associations with increased hyperuricemia in the C8 cohort (Steenland et al., 2010) as well as increased current thyroid disease in the U.S. population (Melzer et al., 2010), based on cross-sectional study…”
BackgroundResultInfluentialGenuis, S. J., Liu, Y., Genuis, Q. I. T., & Martin, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114295 · Cited by 22
Serum levels of perfluorinated compounds in the general population in Shenzhen, China
Li, X., Zhang, J., Liu, W., Li, X., Zhang, X., Jiang, Y., Zhou, J., & Jin, Y. (2011) · Chinese Science Bulletin · doi:10.1007/s11434-011-4616-7 · Cited by 21
Treatment Options for the Removal and Degradation of Polyfluorinated Chemicals
Lutze, H. V., Panglisch, S., Bergmann, A., & Schmidt, T. C. (2011) · The handbook of environmental chemistry · doi:10.1007/978-3-642-21872-9_6 · Cited by 27
Batayi, B., Okonkwo, J. O., & Daso, A. P. (2021) · Water SA · doi:10.17159/wsa/2021.v47.i1.9445 · Cited by 26
Kaiser, A.-M., Jeddi, M. Z., Uhl, M., Jornod, F., Fernández, M. F., & Audouze, K. (2022) · Toxics · doi:10.3390/toxics10080449 · Cited by 23
Darling, A., Patton, H., Rasheduzzaman, M., Guevara, R., McCray, J., Krometis, L., & Cohen, A. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.164036 · Cited by 23
Wang, Y., Warner, M., Li, K., Hawkins, G. L., & Huang, Q. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134547 · Cited by 21
Umweltbundesamt (2018) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-018-2709-z · Cited by 22
Feng, Y., Fu, M., Guan, X., Wang, C., Meng, H., Zhou, Y., He, M., & Guo, H. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136438 · Cited by 21
Potential human health effects of perfluorinated chemicals (PFCs)
Webster, G. M. (2010) · Cited by 33
Nilsson, S., Smurthwaite, K. S., Aylward, L. L., Kay, M. P., Toms, L.-M. L., King, L., Marrington, S., Kirk, M., Mueller, J. F., & Bräunig, J. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114370 · Cited by 19
Fang, H., Chang, H., Chen, D., Qiu, W., Fang, J., Wu, Y., & Peng, X. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117599 · Cited by 16
Serum concentrations of perfluorinated compounds among children living in Sicily (Italy)
Ledda, C., Torre, G. L., Cinà, D., Paravizzini, G., Vitale, E., Pavone, P., Iavicoli, I., & Rapisarda, V. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.09.001 · Cited by 17
Tian, Y., Xing, J., Huyan, C., Zhu, C., Du, D., Zhu, W., Lin, Y., & Chowdhury, I. (2021) · ACS ES&T Water · doi:10.1021/acsestwater.1c00239 · Cited by 18
Association between exposure to perfluoroalkyl substances and uric acid in Chinese adults
Yang, Z., Men, K., Guo, J., Liu, R., Liu, H., Wei, J., Zhang, J., Liu, L., Lin, X., Zhang, M., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.137164 · Cited by 15
Zheng, T., Zhu, C., Bassig, B. A., Liu, S., Buka, S. L., Zhang, X., Truong, A., Jun-hi, O. H., Fulton, J. P., Dai, M., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz136 · Cited by 15
Sulfate radical based oxidation in water treatment
Lutze, H. V. (2014) · DuEPublico (University of Duisburg-Essen) · Cited by 27
Perfluoroalkyl acids: Recent activities and research progress
Lau, C. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.011 · Cited by 15
Bursian, S. J., Link, J. E., McCarty, M., Harr, K. E., Roberts, J., & Simcik, M. F. (2021) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5138 · Cited by 14
“There is some evidence in humans for an association between chronic kidney disease based on estimated glomerular filtration rate and exposure to PFAS (Steenland et al. 2010; Shankar et al. 2011; Watkins et al. 2013).”
BackgroundAmin, M. A., Luo, Y., Nolan, A. L., Megharaj, M., Naidu, R., & Fang, C. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138012 · Cited by 14
Lee, W. K., Wan, H. T., CHENG, Z., Wing Yee, C. H. A. N., Lam, T. K. Y., Lai, K. P., Wang, J., Cai, Z., & Wong, C. K. C. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c02623 · Cited by 12
Khalil, N., Lee, M., & Steenland, K. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15518-0_13 · Cited by 12
Self-citationLiu, Y., Su, G., Wang, F., Jia, J., Li, S., Zhao, L., Shi, Y., Cai, Y., Zhu, H., Zhao, B., et al. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b01635 · Cited by 15
Rigden, M. D., Pelletier, G., Poon, R. W. M., Zhu, J., Auray‐Blais, C., Gagnon, R., Kubwabo, C., Kosarac, I., Lalonde, K., Cakmak, S., et al. (2014) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-014-0058-y · Cited by 11
“…hyperuricemia, decreased glomerular filtration rate, and chronic kidney disease are associated with greater serum PFOA levels (Shankar et al. 2011; Steenland et al. 2010), but it is not yet clear if these increased levels are a cause or a consequence of impaired renal functions (Watkins et al.…”
BackgroundFrom Exposure to Dysfunction: The Intestinal Toxicity of Per- and Polyfluoroalkyl Substances
Brunetti, K., Galletti, G. S., Catalani, E., Cervia, D., & Quondam, S. D. (2025) · Toxics · doi:10.3390/toxics14010039 · Cited by 8
“Indeed, in highly contaminated areas, serum PFOA levels may reach 83.0 ng/mL in residents [31] and exceed 5000 ng/mL in occupational settings [32].”
InfluentialYang, M., Zhao, J., An, Z., Li, H., Ma, C., Lv, J., Xiao, F., Tan, Z., Li, L., Zhang, X., et al. (2024) · Journal of Environmental Sciences · doi:10.1016/j.jes.2024.03.022 · Cited by 8
Epidemiological perspectives on emerging contaminants and gout or hyperuricemia
Fu, W., Guang, Y., Zhang, Z., Zhou, C., & Fang, X. (2025) · Emerging contaminants · doi:10.1016/j.emcon.2025.100485 · Cited by 8
Suitability of Remediated PFAS-Affected Soil in Cement Pastes and Mortars
Fehérvári, A., Gates, W. P., Gallage, C., & Collins, F. (2020) · Sustainability · doi:10.3390/su12104300 · Cited by 8
Michaels, R. A. (2017) · Environmental Claims Journal · doi:10.1080/10406026.2016.1270666 · Cited by 7
Exposure assessment of tetrafluoroethylene and ammonium perfluorooctanoate 1951–2002
Sleeuwenhoek, A., & Cherrie, J. W. (2012) · Journal of Environmental Monitoring · doi:10.1039/c2em10930a · Cited by 9
Tripathi, D., Singh, S., & Ahamad, K. U. (2025) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2025.118453 · Cited by 6
Manoochehri, Z., Shoshtari-Yeganeh, B., Gheisari, L., & Ebrahimpour, K. (2024) · Journal of Environmental Health Science and Engineering · doi:10.1007/s40201-024-00930-0 · Cited by 9
“Associations have been demonstrated between blood levels of PFOS and PFOA and hyperuricemia [26] as well as attention-deficit/hyperactivity disorder in children [26] and reduced immune response to vaccination [27].”
Liu, W., Lin, C.-H., Tsai, C., Wang, H., Li, S., Liu, T., Tan, A. C., Tsou, H., Tseng, K.-H., & Lin, C. (2023) · Bioengineering · doi:10.3390/bioengineering10010089 · Cited by 6
“Previous studies have shown that higher PFOS levels may induce an increase in uric acid and liver function markers [24].”
BackgroundConventional Laboratory Tests to Assess Toxin Burden.
Pizzorno, J. E. (2015) · PubMed · Cited by 5
Removal of perfluorinated compounds from wastewaters by electrochemical methods: A general review
Wang, C., Shang, E., & Niu, J. (2017) · Scientia Sinica Technologica · doi:10.1360/n092017-00116 · Cited by 5
Lü, L., Wang, F., Kang, T., Cheng, S., & Wang, Y. (2011) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(10)60426-4 · Cited by 4
Photocatalytic Degradation of Perfluorooctanoic Acid
Zhang, P., & Li, Z. (2014) · Lecture notes in nanoscale science and technology · doi:10.1007/978-3-319-06578-6_3 · Cited by 3
Xiao, F. (2012) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 6
Metadata
- Authors
- Steenland, K., Tinker, S., Shankar, A., & Ducatman, A.
- Affiliations
- Emory University (US)
- West Virginia University (US)
- Corresponding author
- Steenland, Kyle
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-10-22
- Volume
- 118
- Issue
- 2
- Pages
- 229-233
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- PMC
- PMC2831922
- OpenAlex
- W2008547378
- Cited by
- 224
- References
- 41
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 14 · 2021: 13 · 2020: 16 · 2019: 14 · 2018: 16 · 2017: 17 · 2016: 10 · 2015: 14 · 2014: 17 · 2013: 15 · 2012: 17
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/licenses/by/4.0/ (vor, 2990 d)
- Locations
- Environmental Health Perspectives (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- The Research Repository @ WVU (West Virginia University) (submittedVersion)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Environmental Science › Water Science and Technology › Fluoride Effects and Removal
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- perfluorooctanoic acid, PFOS, uric acid, hyperuricemia, water pollution, community exposure, cardiovascular risk factors, hypertension, fluorinated compounds
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Caprylates, Environmental Pollutants, Female, Fluorocarbons, Humans, Male, Middle Aged, Ohio, Uric Acid, West Virginia, Linear Models, Alkanesulfonic Acids, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.